Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, held its first Annual Meeting of Stockholders virtually on August 31, 2026. Shareholders approved several key proposals that could significantly alter the company's capital structure and governance, as detailed in the meeting results (https://ibn.fm/HIqJ9).
Shareholders authorized the Board of Directors to pursue a reverse stock split within a 12-month period, if deemed necessary to meet the bid price requirements for an uplisting to a national exchange such as Nasdaq or NYSE. The decision on whether to execute the split remains with the Board. CEO and Chairman Giorgio R. Saumat emphasized that he will not support a split unless it is required for the uplisting.
In a move to simplify its capital structure, stockholders authorized the Board's Independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This retirement would eliminate the company's current dual-class voting structure, potentially giving common shareholders greater influence over corporate decisions.
Additionally, shareholders ratified the appointment of Semple, Marchal & Cooper LLP as an independent registered public accounting firm, re-elected seven director nominees, and authorized a new non-dilutive executive compensation framework. The compensation framework is designed to align management incentives with shareholder interests without diluting existing equity.
These approvals signal a strategic push toward uplisting and improved corporate governance. An uplisting to a major exchange could enhance ETST's visibility, liquidity, and access to institutional investors, potentially increasing shareholder value. The retirement of the Series B Preferred Stock would streamline voting rights and could make the company more attractive to a broader investor base.
For investors, these developments may indicate a commitment to growth and transparency. However, the reverse stock split, if implemented, could temporarily impact share price and market capitalization, though it is intended to meet exchange listing standards. The non-dilutive compensation framework may also reassure shareholders concerned about equity dilution.
Earth Science Tech operates in the healthcare, pharmacy, and telemedicine sectors, and these governance changes could position it for expanded opportunities in these growing markets. The company's newsroom is available at https://ibn.fm/ETST for further updates.
The outcome of the annual meeting reflects shareholder confidence in the company's strategic direction. As ETST advances its uplisting efforts, the market will watch closely to see if these measures lead to increased investor engagement and long-term value creation.
